Mark S. Huberman: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Ruderman-Kittel-Kasuya-Yosida interaction in thin wires

Bergmann, Gerd, Shieh, William, Huberman, Mark

Journal:

Physical Review B

Year:

1992

Language:

english

File:

PDF, 113 KB

english, 1992

2

EGFR testing in advanced non-small-cell lung cancer, a mini-review

Sheikine, Yuri, Rangachari, Deepa, McDonald, Danielle C., Huberman, Mark S., Folch, Erik S., VanderLaan, Paul A., Costa, Daniel B.

Journal:

Clinical Lung Cancer

Year:

2016

Language:

english

File:

PDF, 1.13 MB

english, 2016

3

Influence of multimodality therapy on the management of pancreas carcinoma

J. Milburn Jessup, Marshall Posner, Mark Huberman

Journal:

Seminars in Surgical Oncology

Year:

1993

Language:

english

File:

PDF, 562 KB

english, 1993

4

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors

Le, Xiuning, Desai, Neelam V., Majid, Adnan, Karp, Rebecca S., Huberman, Mark S., Rangachari, Deepa, Kent, Michael S., Gangadharan, Sidharta P., Folch, Erik, VanderLaan, Paul A., Costa, Daniel B.

Journal:

Year:

2015

Language:

english

File:

PDF, 1.48 MB

english, 2015

5

Impact of combined modality therapy on the treatment of adenocarcinoma of the colon

Marshall R. Posner, Ronald Bleday, Mark Huberman, John M. Jessup, Paul Busse, Glenn Steele Jr.

Journal:

Seminars in Surgical Oncology

Year:

1993

Language:

english

File:

PDF, 586 KB

english, 1993

6

A Phase II Study of Oxaliplatin, Pemetrexed, and Bevacizumab in Previously Treated Advanced Non-small Cell Lung Cancer

Heist, Rebecca Suk, Fidias, Panos, Huberman, Mark, Ardman, Blair, Sequist, Lecia V., Temel, Jennifer S., Lynch, Thomas J.

Journal:

Journal of Thoracic Oncology

Year:

2008

Language:

english

File:

PDF, 327 KB

english, 2008

7

De novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancers

Lucena-Araujo, Antonio R., Moran, Jason P., VanderLaan, Paul A., Dias-Santagata, Dora, Folch, Erik, Majid, Adnan, Kent, Michael S., Gangadharan, Sidharta P., Rangachari, Deepa, Huberman, Mark S., Koba

Journal:

Year:

2016

Language:

english

File:

PDF, 2.45 MB

english, 2016

8

NIH Public Access

Yeo, Wee-lee, Riely, Gregory J, Yeap, Beow Y, Lau, Michelle W, Warner, Jeremy L, Bodio, Kelly, Huberman, Mark S, Kris, Mark G, Tenen, Daniel G, Pao, William, Costa, Daniel B

Year:

2011

Language:

english

File:

PDF, 166 KB

english, 2011

9

T1 SIZE DESCRIPTOR SHOULD BE SUBDIVIDED FOR STAGE IA (T1N0) NON-SMALL CELL LUNG CANCER FOR BETTER PROGNOSTIC VALUE

Ye, Chao, Masterman, Justin R., Gautam, Shiva, Huberman, Mark S., Gangadharan, Sidharta P., McDonald, Danielle M., DeCamp, Malcolm M.

Journal:

Year:

2008

Language:

english

File:

PDF, 64 KB

english, 2008

10

Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Neal, Joel W., Heist, Rebecca S., Fidias, Panos, Temel, Jennifer S., Huberman, Mark, Marcoux, J. Paul, Muzikansky, Alona, Lynch, Thomas J., Sequist, Lecia V.

Journal:

Journal of Thoracic Oncology

Year:

2010

Language:

english

File:

PDF, 109 KB

english, 2010

11

EGFR exon 20 insertion mutations display sensitivity to Hsp90 inhibition in preclinical models and lung adenocarcinomas

Jorge, Susan, Lucena-Araujo, Antonio Roberto, Yasuda, Hiroyuki, Piotrowska, Zofia, Oxnard, Geoffrey R., Rangachari, Deepa, Huberman, Mark, Sequist, Lecia V., Kobayashi, Susumu S., Costa, Daniel B.

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 1.39 MB

english, 2018

12

P-611 Final results from a phase II study of erlotinib (TarcevaTM) monotherapy in patients with advanced non-small cell lung cancer following failure of platinum-based chemotherapy

Perez-Soler, Roman, Chachoua, Abraham, Huberman, Mark, Karp, Daniel, Rigas, James, Hammond, Lisa, Rowinsky, Eric, Clark, Gary, Santabárbara, Pedro, Bonomi, Philip

Journal:

Year:

2003

Language:

english

File:

PDF, 369 KB

english, 2003

13

Pulse afatinib for ERBB2 exon 20 insertion mutated lung adenocarcinomas

Costa, Daniel B., Jorge, Susan E., Moran, Jason P., Freed, Jason A., Zerillo, Jessica A., Huberman, Mark S., Kobayashi, Susumu S.

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 489 KB

english, 2016

14

Peripheral neurotoxicity of taxol in patients previously treated with cisplatin

Ajay Anand, Mark Huberman, Guido Cavaletti, Giovanni Tredici

Journal:

Year:

1995

Language:

english

File:

PDF, 186 KB

english, 1995

15

Gemcitabine Pulmonary Toxicity: CT Features

Boiselle, Phillip M., Morrin, Martina M., Huberman, Mark S.

Journal:

Journal of Computer Assisted Tomography

Year:

2000

Language:

english

File:

PDF, 364 KB

english, 2000

16

Correcting for Exposure Measurement Error in a Reanalysis of lung cancer Mortality for the Colorado Plateau Uranium Miners Cohort

Stram, Daniel O., Langholz, Bryan, Huberman, Mark, Thomas, Duncan C.

Journal:

Year:

1999

Language:

english

File:

PDF, 283 KB

english, 1999

17

Correlation between Classic Driver Oncogene Mutations in EGFR , ALK , or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma

Rangachari, Deepa, VanderLaan, Paul A., Shea, Meghan, Le, Xiuning, Huberman, Mark S., Kobayashi, Susumu S., Costa, Daniel B.

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 734 KB

english, 2017

18

Lazarus-type response to crizotinib in a patient with poor performance status and advanced MET exon 14 skipping mutation-positive lung adenocarcinoma

Shea, Meghan, Huberman, Mark S., Costa, Daniel B.

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 657 KB

english, 2016

19

Cases of ALK -rearranged lung cancer with 5-year progression-free survival with crizotinib as initial precision therapy

Rangachari, Deepa, Le, Xiuning, Shea, Meghan, Huberman, Mark S., VanderLaan, Paul A., Kobayashi, Susumu S., Costa, Daniel B.

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 2.59 MB

english, 2017

20

Hepatic involvement in the cutaneous T-cell lymphomas. Results of percutaneous biopsy and peritoneoscopy

Mark S. Huberman, Paul A. Bunn Jr., Mary J. Matthews, Daniel C. Ihde, Adi F. Gazdar, Martin H. Cohen, John D. Minna

Journal:

Year:

1980

Language:

english

File:

PDF, 586 KB

english, 1980

21

Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial

Tomislav Dragovich, Mark Huberman, Daniel D. Von Hoff, Eric K. Rowinsky, Paul Nadler, Debra Wood, Marta Hamilton, George Hage, Julie Wolf, Amita Patnaik

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2007

Language:

english

File:

PDF, 310 KB

english, 2007

22

Erlotinib at a Dose of 25 mg Daily for Non-small Cell Lung Cancers with EGFR Mutations

Yeo, Wee-Lee, Riely, Gregory J., Yeap, Beow Y., Lau, Michelle W., Warner, Jeremy L., Bodio, Kelly, Huberman, Mark S., Kris, Mark G., Tenen, Daniel G., Pao, William, Kobayashi, Susumu, Costa, Daniel B.

Journal:

Journal of Thoracic Oncology

Year:

2010

Language:

english

File:

PDF, 285 KB

english, 2010

23

Adriamycin, cyclophosphamide, and etoposide (VP-16–213) in extensive-stage small cell lung cancer

Matelski, Harry W., Lokich, Jacob J., Huberman, Mark S., Zipoli, Thomas E., Paul, Steven, Sonneborn, Henry, Philips, Donald

Journal:

American Journal of Clinical Oncology

Year:

1984

File:

PDF, 246 KB

1984

24

Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer

Sequist, Lecia V., Fidias, Panos M., Temel, Jennifer S., Kolevska, Tatjana, Rabin, Michael S., Boccia, Ralph V., Burris, Howard A., Belt, Robert J., Huberman, Mark S., Melnyk, Ostap, Mills, Glenn M.,

Journal:

Journal of Thoracic Oncology

Year:

2009

Language:

english

File:

PDF, 113 KB

english, 2009

25

Exact formulae for the electrical resistivity

Huberman, Mark, Chester, G.V.

Journal:

Advances In Physics

Year:

1975

Language:

english

File:

PDF, 1.40 MB

english, 1975

26

IMon-Hodgkin’s Lymphoma of the Kidney with Inferior Vena Caval Extension

Eyre, Robert C., Huberman, Mark S., Balogh, Karoly

Journal:

Urologia Internationalis

Year:

1993

Language:

english

File:

PDF, 619 KB

english, 1993

27

P3-096: Phase II study of erlotinib in chemoânaÃ¯ve women with advanced pulmonary adenocarcinoma.

Jackman, David M., Lindeman, Neal, Lucca, Joan, Morse, Linda K., Rabin, Michael S., Marcoux, J.P., Huberman, Mark S., Johnson, Bruce E., Janne, Pasi A.

Journal:

Journal of Thoracic Oncology

Year:

2007

File:

PDF, 209 KB

2007

28

Nonrandomized Comparison of Surgery With and Without Adjuvant Pelvic Irradiation for Patients With pT3N0 Adenocarcinoma of the Prostate

Petrovich, Zbigniew, Lieskovsky, Gary, Langholz, Bryan, Huberman, Mark, Streeter, Oscar, Skinner, Donald G.

Journal:

American Journal of Clinical Oncology

Year:

2001

Language:

english

File:

PDF, 123 KB

english, 2001

29

A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma

Pedro M. Sanz-Altamira, Karen Ferrante, Roger L. Jenkins, W. David Lewis, Mark S. Huberman, Keith E. Stuart

Journal:

Year:

1998

Language:

english

File:

PDF, 65 KB

english, 1998

30

Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells

Christina L. Chang, Nividita Hora, Nina Huberman, Robert Hinderer, Mark KuKuruga, Samir M. Hanash

Journal:

Year:

2001

Language:

english

File:

PDF, 2.44 MB

english, 2001

31

Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell Lung Cancer

Folch, Erik, Yamaguchi, Norihiro, VanderLaan, Paul A., Kocher, Olivier N., Boucher, David H., Goldstein, Michael A., Huberman, Mark S., Kent, Michael S., Gangadharan, Sidharta P., Costa, Daniel B., Ma

Journal:

Journal of Thoracic Oncology

Year:

2013

Language:

english

File:

PDF, 715 KB

english, 2013

32

Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes

VanderLaan, Paul A., Rangachari, Deepa, Mockus, Susan M., Spotlow, Vanessa, Reddi, Honey V., Malcolm, Joan, Huberman, Mark S., Joseph, Loren J., Kobayashi, Susumu S., Costa, Daniel B.

Journal:

Year:

2017

Language:

english

File:

PDF, 802 KB

english, 2017

33

Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers

Costa, Daniel B., Kobayashi, Susumu, Tenen, Daniel G., Huberman, Mark S.

Journal:

Year:

2007

Language:

english

File:

PDF, 171 KB

english, 2007

34

Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling

Le, Xiuning, Freed, Jason A., VanderLaan, Paul A., Huberman, Mark S., Rangachari, Deepa, Jorge, Susan E., Lucena-Araujo, Antonio R., Kobayashi, Susumu S., Balasubramanian, Sohail, He, Jie, Chudnovsky,

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 846 KB

english, 2015

35

Experience with targeted next generation sequencing for the care of lung cancer: Insights into promises and limitations of genomic oncology in day-to-day practice

Rangachari, Deepa, VanderLaan, Paul A., Le, Xiuning, Folch, Erik, Kent, Michael S., Gangadharan, Sidharta P., Majid, Adnan, Haspel, Richard L., Joseph, Loren J., Huberman, Mark S., Costa, Daniel B.

Journal:

Cancer Treatment Communications

Year:

2015

Language:

english

File:

PDF, 321 KB

english, 2015

36

Ascertainment Bias in Rate Ratio Estimation from Case-Sibling Control Studies of Variable Age-at-Onset Diseases

Bryan Langholz, Argyrios Ziogas, Duncan C. Thomas, Cheryl Faucett, Mark Huberman and Larry Goldstein

Journal:

Year:

1999

Language:

english

File:

PDF, 1.70 MB

english, 1999

37

Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients with Non-Small-Cell Lung Cancer

Ostios-Garcia, Lorena, Faig, Jennifer, Leonardi, Giulia C., Adeni, Anika E., Subegdjo, Safiya J., Lydon, Christine A., Rangachari, Deepa, Huberman, Mark S., Sehgal, Kartik, Shea, Meghan, VanderLaan, P

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 884 KB

english, 2018

38

P1.02-031 Mutations in TP53, PIK3CA, PTEN and Other Genes in EGFR Mutated Lung Cancers: Correlation with Clinical Outcomes

Vanderlaan, Paul, Rangachari, Deepa, Mockus, Susan, Spotlow, Vanessa, Reddi, Honey, Malcom, Joan, Huberman, Mark, Joseph, Loren, Kobayashi, Susumu, Costa, Daniel

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 125 KB

english, 2017

39

Cisplatin and Chronic Oral Etoposide as Salvage Therapy for Advanced Colorectal Carcinoma

Stuart, Keith, Posner, Marshall, Campbell, Kathleen, Huberman, Mark

Journal:

American Journal of Clinical Oncology

Year:

1995

File:

PDF, 215 KB

1995

40

Correction: EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas

Jorge, Susan E., Lucena-Araujo, Antonio R., Yasuda, Hiroyuki, Piotrowska, Zofia, Oxnard, Geoffrey R., Rangachari, Deepa, Huberman, Mark S., Sequist, Lecia V., Kobayashi, Susumu S., Costa, Daniel B.

Journal:

Clinical Cancer Research

Year:

2020

File:

PDF, 182 KB

2020

41

Su1883 Occurrence of Esophageal Symptoms After Radiation and/or Chemotherapy in Patients With Lung Cancer Compared to Patients With Breast Cancer or Lymphoma

Shields, Helen M., Li, Justin W., Wang, Helen H., Pelletier, Stephen R., Freedman, Rachel, Mamon, Harvey, Ng, Andrea K., Freedman, Arnold, Come, Steven, Avigan, David, Huberman, Mark, Recht, Abram

Journal:

Gastroenterology

Year:

2013

Language:

english

File:

PDF, 130 KB

english, 2013

42

Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation

Jorge, Susan E., Schulman, Sol, Freed, Jason A., VanderLaan, Paul A., Rangachari, Deepa, Kobayashi, Susumu S., Huberman, Mark S., Costa, Daniel B.

Journal:

Year:

2015

Language:

english

File:

PDF, 1.51 MB

english, 2015

43

Persistence of dysphagia and odynophagia after mediastinal radiation and chemotherapy in patients with lung cancer or lymphoma

Shields, Helen, Li, Justin, Pelletier, Stephen, Wang, Helen, Freedman, Rachel, Mamon, Harvey, Ng, Andrea, Freedman, Arnold, Come, Steven, Avigan, David, Huberman, Mark, Recht, Abram

Journal:

Diseases of the Esophagus

Year:

2016

Language:

english

File:

PDF, 274 KB

english, 2016

44

Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma

Pedro M. Sanz-Altamira, Liam D. Spence, Mark S. Huberman, Marshall R. Posner, Glenn Steele, Laura J. Perry, Keith E. Stuart

Journal:

Diseases of the Colon & Rectum

Year:

1997

Language:

english

File:

PDF, 529 KB

english, 1997

45

Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer

VanderLaan, Paul A., Yamaguchi, Norihiro, Folch, Erik, Boucher, David H., Kent, Michael S., Gangadharan, Sidharta P., Majid, Adnan, Goldstein, Michael A., Huberman, Mark S., Kocher, Olivier N., Costa,

Journal:

Year:

2014

Language:

english

File:

PDF, 947 KB

english, 2014

46

BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

Costa, Daniel B., Halmos, Balázs, Kumar, Amit, Schumer, Susan T., Huberman, Mark S., Boggon, Titus J., Tenen, Daniel G., Kobayashi, Susumu

Journal:

Year:

2007

Language:

english

File:

PDF, 836 KB

english, 2007

47

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Nonâsmall-cell Lung Cancer

Sehgal, Kartik, Bulumulle, Anushi, Brody, Heather, Gill, Ritu R., Macherla, Shravanti, Qilleri, Aleksandra, McDonald, Danielle C., Cherry, Cynthia R., Shea, Meghan, Huberman, Mark S., VanderLaan, Paul

Journal:

Clinical Lung Cancer

Year:

2020

File:

PDF, 821 KB

2020

48

Ascertainment Bias in Rate Ratio Estimation from Case-Sibling Control Studies of Variable Age-At-Onset Diseases

Bryan Langholz, Argyrios Ziogas, Duncan C. Thomas, Cheryl Faucett, Mark Huberman, Larry Goldstein

Journal:

Year:

1999

Language:

english

File:

PDF, 876 KB

english, 1999

49

Exact formulae for the electrical resistivity

Huberman, Mark, Chester, G.V.

Journal:

Advances In Physics

Year:

1975

File:

PDF, 1.40 MB

1975

50

Use of Lymph Node Aspirates From Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non-small Cell Lung Cancer

Folch, Erik, Yamaguchi, Norihiro, Vanderlaan, Paul, Kent, Michael, Gangadharan, Sidharta, Goldstein, Michael, Huberman, Mark, Costa, Daniel, Majid, Adnan

Journal:

Year:

2013

Language:

english

File:

PDF, 248 KB

english, 2013

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски